Cure Alzheimer’s Fund presents: TAKING CONTROL OF ALZHEIMER’S THROUGH RESEARCH Thank you to all who attended our Symposium on Oct. 18 in Boston. Below are questions and answers that were submitted that day. Presenters MODERATOR Robert Bazell, Chief Science & Health Correspondent, NBC News PANEL Rudolph Tanzi, Ph.D., Harvard Medical School/Massachusetts General Hospital; Chairman, CureAlz Research Consortium Robert Moir, ...
August 12, 2011
July 16, 2018
SUMMARY After declaring aducanumab a failure, new data from Biogen’s clinical trial suggests the drug may help slow cognitive decline in some patients. In the EMERGE trial for aducanumab, patients receiving the highest dose saw 23% less cognitive decline on the Clinical Dementia Rating-Sum of Boxes test in comparison to patients receiving ...
October 30, 2019
Cure Alzheimer’s Fund presented a webinar, Two Sides of Abeta for the Layperson, on Wednesday, Jan. 25, 2012. The presentation, moderated by David Shenk, author of the national bestseller The Forgetting, Alzheimer’s: Portrait of an Epidemic, featured Dr. Rudy Tanzi and Dr. Rob Moir. These Alzheimer’s experts looked at Abeta and ...
January 25, 2012
Prepared by: Rudolph E. Tanzi, Ph.D. Chairperson, Cure Alzheimer’s Fund Research Consortium Joseph P. and Rose F. Kennedy Professor of Neurology Harvard Medical School, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease Department of Neurology Massachusetts General Hospital 114 16th Street Charletown, MA [email protected] Timothy W. Armour President and CEO Cure Alzheimer’s Fund 34 Washington Street Suite 300 Wellesly Hills, MA [email protected] The ...
August 20, 2009
Cure Alzheimer’s Fund’s Dr. Rudy Tanzi’s submitted answers to Senator Hillary Rodham Clinton’s questions from the May 14, 2008, Senate Special Committee on Aging “The Future of Alzheimer’s: Breakthroughs and Challenges” Questions How can we best identify those at risk for Alzheimer’s Disease? Are there effective new drugs coming out anytime soon? How critical ...
June 8, 2008
The Four Known Alzheimer’s Genes Over the past several decades, it has become increasingly clear that inheritance plays a major role in Alzheimer’s disease. The roughly 25,000 genes in the human genome are comprised of deoxyribonucleic acid (DNA) packaged into 24 different chromosomes, 1-22, X and Y. A gene’s job is ...
April 18, 2011
On Feb. 22, 2012, the Department of Health and Human Services issued the first “Draft National Plan to Address Alzheimer’s Disease.” The plan is mandated by the National Alzheimer’s Project Act (NAPA), bipartisan legislation signed into law in January 2011 by President Obama. NAPA’s goals are to: Create and maintain an ...
February 24, 2012
A new blood test, which has the potential to accurately diagnose Alzheimer’s disease in individuals and significantly advance drug testing and research on the disease, has been developed through grant funding by Cure Alzheimer’s Fund. The test, known as Immunosignature (IS) and developed by a team led by UCLA neurologist Lucas ...
April 28, 2014
You are invited to participate in an exclusive Catalyst Society Video Conference with a member of the Cure Alzheimer’s Fund Research Consortium. Clinician, scientist and policy leader Murali Doraiswamy, M.D., will speak about research progress and give insights into sex-based, ethnic and racial disparity in the diagnosis of the disease. The presentation will start promptly at 1 ...
July 9, 2017
